RxDoctor Payments Data

Melanie McCarty

Family · Owensboro, KYNPI 1225519432

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Gilead accounts for 85.5% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $9,721 and has fallen 61.3% since, to $3,763 in 2025. Among family clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,979in general payments, 2019–2025

Across 162 payments — averaging $92.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$13K
  • AbbVie$750
  • USWM, LLC$525
  • Lilly USA, LLC$184
  • Alkermes, Inc.$179
  • AstraZeneca$127
  • plus $400 from 12 others

What the payments were for

  • Consulting fees$7,28049%
  • Travel & lodging$4,60731%
  • Food & beverage$2,53917%
  • Education$460%
  • Gifts$5063%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,979 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpclusaSofosbuvir/Velpatasvir11$261,491
MounjaroTirzepatide46$59,471
JardianceEmpagliflozin36$32,663
Nurtec OdtRimegepant Sulfate12$26,709
OzempicSemaglutide25$25,705
Breo ElliptaFluticasone/Vilanterol25$9,638
EliquisApixaban12$6,708
Tresiba Flextouch U-200Insulin Degludec16$6,160
Spiriva RespimatTiotropium Bromide12$5,964
Ventolin HfaAlbuterol Sulfate16$873
Albuterol Sulfate HfaAlbuterol Sulfate28$479
Amlodipine Besylate83$433
Atorvastatin Calcium78$360
Levothyroxine Sodium39$259
Metoprolol Succinate15$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadEpclusa$12,814$261,49111 claims
Lilly USA, LLCMounjaro$184$59,47146 claims
PfizerNurtec Odt, Eliquis$37$33,41724 claims
Novo NordiskOzempic$63$25,70525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.

Other family in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →